Serving as Wall Street Daily's Senior Analyst, Jonathan has helped develop successful products that earned readers triple-digit gains. With a focus in options trading, he has worked alongside the brightest minds in the financial industry to uncover timely and profitable investment opportunities. Before joining WSD, Jonathan spent nearly a decade in retail management and client relations with Fortune 500 companies. He earned a Bachelor of Arts with honors from Old Dominion University.
Before the general public can benefit from the most revolutionary gene-editing technique of the 21st century, the U.S. Patent and Trademark Office has to figure out who the technology even belongs to — and who will profit.
Donald Trump ran a campaign on hyperbole and vagueness. Now as he prepares to take office, we take a closer look at his contradictory statements on science to make sense of the future of our favored industries.
It’s easy to dismiss celebrities and politicians as having hidden agendas. On the other hand, scientists that uncover cold, hard facts, deserve our respect for their endeavors. But respect is not worship.